Terms: = Liver cancer AND FANCG, ENSG00000221829, 2189, O15287, XRCC9, FAG
19 results:
1. Clinicopathological and molecular characterization of chromophobe hepatocellular carcinoma.
Kang HJ; Oh JH; Kim YW; Kim W; An J; Sung CO; Kim J; Shim JH; Hwang S; Yu E; Heaphy CM; Hong SM
Liver Int; 2021 Oct; 41(10):2499-2510. PubMed ID: 34036718
[TBL] [Abstract] [Full Text] [Related]
2. Natural History of Incidental Enhancing Nodules on Cone-Beam Computed Tomography during Transarterial Therapy of Hepatocellular Carcinoma.
Elboraey M; Devcic Z; Montazeri SA; Li X; Lewis AR; Ritchie CA; Frey GT; Paz-Fumagalli R; McKinney JM; Toskich BB
J Vasc Interv Radiol; 2021 Aug; 32(8):1186-1192.e1. PubMed ID: 33901694
[TBL] [Abstract] [Full Text] [Related]
3. Application of liver acquisition with volume acceleration enhanced sequence in improving the accuracy of reassessing organ-invasive rectal mucinous adenocarcinoma after chemoradiation.
Cao W; Zou Q; Zhao Y; Zhou J; Li W; Ren D; Meng X; Hu B; Zhou Z
Eur J Radiol; 2020 Dec; 133():109368. PubMed ID: 33207287
[TBL] [Abstract] [Full Text] [Related]
4. A historical cohort study on glycemic-control and cancer-risk among patients with diabetes.
Dankner R; Boker LK; Boffetta P; Balicer RD; Murad H; Berlin A; Olmer L; Agai N; Freedman LS
Cancer Epidemiol; 2018 Dec; 57():104-109. PubMed ID: 30388485
[TBL] [Abstract] [Full Text] [Related]
5. The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management.
Marchegiani G; Andrianello S; Perri G; Pollini T; Caravati A; Secchettin E; Malleo G; Bassi C; Salvia R
Dig Liver Dis; 2018 Dec; 50(12):1327-1333. PubMed ID: 29941281
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.
Peraldo-Neia C; Ostano P; Cavalloni G; Pignochino Y; Sangiolo D; De Cecco L; Marchesi E; Ribero D; Scarpa A; De Rose AM; Giuliani A; Calise F; Raggi C; Invernizzi P; Aglietta M; Chiorino G; Leone F
BMC Genomics; 2018 Jun; 19(1):440. PubMed ID: 29871612
[TBL] [Abstract] [Full Text] [Related]
7. Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.
Lu JG; Nguyen L; Samadzadeh S; Masouminia M; Mendoza A; Sweeney O; Tillman B; Afifyan N; Morgan T; French BA; French SW
Exp Mol Pathol; 2018 Apr; 104(2):125-129. PubMed ID: 29425759
[TBL] [Abstract] [Full Text] [Related]
8. Can oesophagectomy be performed for patients with oesophageal carcinoma and concomitant liver cirrhosis? A retrospective study based on a propensity-matched cohort.
Wang ZQ; Deng HY; Yang YS; Wang Y; Hu Y; Yuan Y; Wang WP; Chen LQ
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):442-447. PubMed ID: 28520878
[TBL] [Abstract] [Full Text] [Related]
9. [Pleuropulmonary metastases originating from extra-thoracic neoplasia].
Badri F; Batahar SA; Idrissi SE; Sajiai H; Serhane H; Amro L
Pan Afr Med J; 2017; 26():44. PubMed ID: 28451022
[TBL] [Abstract] [Full Text] [Related]
10. Time-Dependent Risk of cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults.
Dankner R; Boffetta P; Balicer RD; Boker LK; Sadeh M; Berlin A; Olmer L; Goldfracht M; Freedman LS
Am J Epidemiol; 2016 Jun; 183(12):1098-106. PubMed ID: 27257115
[TBL] [Abstract] [Full Text] [Related]
11. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.
Heetfeld M; Chougnet CN; Olsen IH; Rinke A; Borbath I; Crespo G; Barriuso J; Pavel M; O'Toole D; Walter T;
Endocr Relat Cancer; 2015 Aug; 22(4):657-64. PubMed ID: 26113608
[TBL] [Abstract] [Full Text] [Related]
12. Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.
Bera R; Chiou CY; Yu MC; Peng JM; He CR; Hsu CY; Huang HL; Ho UY; Lin SM; Lin YJ; Hsieh SY
Hepatology; 2014 Jun; 59(6):2238-50. PubMed ID: 24470239
[TBL] [Abstract] [Full Text] [Related]
13. Surgical treatment of lymph node metastases from hepatocellular carcinoma.
Kobayashi S; Takahashi S; Kato Y; Gotohda N; Nakagohri T; Konishi M; Kinoshita T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):559-66. PubMed ID: 21331804
[TBL] [Abstract] [Full Text] [Related]
14. Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.
Palagyi A; Neveling K; Plinninger U; Ziesch A; Targosz BS; Denk GU; Ochs S; Rizzani A; Meier D; Thasler WE; Hanenberg H; De Toni EN; Bassermann F; Schäfer C; Göke B; Schindler D; Gallmeier E
Mol Cancer; 2010 May; 9():127. PubMed ID: 20509860
[TBL] [Abstract] [Full Text] [Related]
15. Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
Alberts SR; Suman VJ; Pitot HC; Camoriano JK; Rubin J
J Gastrointest Cancer; 2007; 38(1):10-4. PubMed ID: 19065716
[TBL] [Abstract] [Full Text] [Related]
16. Sebaceous carcinoma of the eyelid associated with retinoblastoma.
Kivelä T; Asko-Seljavaara S; Pihkala U; Hovi L; Heikkonen J
Ophthalmology; 2001 Jun; 108(6):1124-8. PubMed ID: 11382640
[TBL] [Abstract] [Full Text] [Related]
17. Tumors of the stomach.
Davis GB; Blanchard DK; Hatch GF; Wertheimer-Hatch L; Hatch KF; Foster RS; Skandalakis JE
World J Surg; 2000 Apr; 24(4):412-20. PubMed ID: 10706913
[TBL] [Abstract] [Full Text] [Related]
18. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
[TBL] [Abstract] [Full Text] [Related]
19. Is carcinoma of the gallbladder a curable lesion?
Wanebo HJ; Castle WN; Fechner RE
Ann Surg; 1982 May; 195(5):624-31. PubMed ID: 7073360
[TBL] [Abstract] [Full Text] [Related]
